Sign in

Trial site

UROMED Jakub Koteras

Szczecin, 71-434, PolandEU-13 widening countryNot linked to an institution yet
  • 2closed trials

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions
Phase
  • Phase 32 trials
Status
  • Completed2 trials
Lead sponsor
  • Celgene International II S.a.r.l.1 trial
  • Celgene International II SARL1 trial

Closed trials

Site data: EU CTIS (euclinicaltrials.eu)Updated 5 Nov 2026

UROMED Jakub Koteras: trial site – Frontlight Research